Larvol Delta - Discovery-of-Investigational-Drug-CT1812-an-Antagonist-of-the-Sigma2-Receptor-Complex-for-Alzheimer39s-Disease

Elayta (CT1812) - Cognition Therap

http://www.ncbi.nlm.nih.gov/pubmed/34531947

Sep 18, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next